945 related articles for article (PubMed ID: 11742418)
1. Biological mechanisms underlying the clinical effects of mifepristone (RU 486) on the endometrium.
Papp C; Schatz F; Krikun G; Hausknecht V; Lockwood CJ
Early Pregnancy (Cherry Hill); 2000 Oct; 4(4):230-9. PubMed ID: 11742418
[TBL] [Abstract][Full Text] [Related]
2. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell stromelysin-1 and prolactin expression.
Schatz F; Papp C; Aigner S; Krikun G; Hausknecht V; Lockwood CJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):188-93. PubMed ID: 8989257
[TBL] [Abstract][Full Text] [Related]
3. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
[TBL] [Abstract][Full Text] [Related]
4. A biological model for the regulation of peri-implantational hemostasis and menstruation.
Lockwood CJ; Schatz F
J Soc Gynecol Investig; 1996; 3(4):159-65. PubMed ID: 8796825
[TBL] [Abstract][Full Text] [Related]
5. Implications of decidualization-associated protease expression in implantation and menstruation.
Schatz F; Krikun G; Runic R; Wang EY; Hausknecht V; Lockwood CJ
Semin Reprod Endocrinol; 1999; 17(1):3-12. PubMed ID: 10406070
[TBL] [Abstract][Full Text] [Related]
6. Regulation of plasminogen activator inhibitor 1 expression by interaction of epidermal growth factor with progestin during decidualization of human endometrial stromal cells.
Lockwood CJ
Am J Obstet Gynecol; 2001 Apr; 184(5):798-804; discussion 804-5. PubMed ID: 11303186
[TBL] [Abstract][Full Text] [Related]
7. Differential localization and expression of urokinase plasminogen activator (uPA), its receptor (uPAR), and its inhibitor (PAI-1) mRNA and protein in endometrial tissue during the menstrual cycle.
Nordengren J; Pilka R; Noskova V; Ehinger A; Domanski H; Andersson C; Høyer-Hansen G; Hansson SR; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):655-63. PubMed ID: 15243126
[TBL] [Abstract][Full Text] [Related]
8. Progestin inhibits and thrombin stimulates the plasminogen activator/inhibitor system in term decidual stromal cells: implications for parturition.
Norwitz ER; Snegovskikh V; Schatz F; Foyouzi N; Rahman M; Buchwalder L; Lee HJ; Funai EF; Buhimschi CS; Buhimschi IA; Lockwood CJ
Am J Obstet Gynecol; 2007 Apr; 196(4):382.e1-8. PubMed ID: 17403427
[TBL] [Abstract][Full Text] [Related]
9. The decidua regulates hemostasis in human endometrium.
Lockwood CJ; Krikun G; Schatz F
Semin Reprod Endocrinol; 1999; 17(1):45-51. PubMed ID: 10406075
[TBL] [Abstract][Full Text] [Related]
10. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation.
Lockwood CJ; Krikun G; Papp C; Toth-Pal E; Markiewicz L; Wang EY; Kerenyi T; Zhou X; Hausknecht V; Papp Z
Ann N Y Acad Sci; 1994 Sep; 734():57-79. PubMed ID: 7978955
[TBL] [Abstract][Full Text] [Related]
11. The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.
Schatz F; Guzeloglu-Kayisli O; Arlier S; Kayisli UA; Lockwood CJ
Hum Reprod Update; 2016 Jun; 22(4):497-515. PubMed ID: 26912000
[TBL] [Abstract][Full Text] [Related]
12. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states.
Lockwood CJ; Krikun G; Rahman M; Caze R; Buchwalder L; Schatz F
Semin Thromb Hemost; 2007 Feb; 33(1):111-7. PubMed ID: 17253197
[TBL] [Abstract][Full Text] [Related]
13. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
14. Biological mechanisms underlying RU 486 clinical effects: inhibition of endometrial stromal cell tissue factor content.
Lockwood CJ; Krikun G; Papp C; Aigner S; Nemerson Y; Schatz F
J Clin Endocrinol Metab; 1994 Sep; 79(3):786-90. PubMed ID: 8077362
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal.
Lockwood CJ; Krikun G; Hausknecht VA; Papp C; Schatz F
Endocrinology; 1998 Nov; 139(11):4607-13. PubMed ID: 9794472
[TBL] [Abstract][Full Text] [Related]
16. Progesterone induces the fibulin-1 expression in human endometrial stromal cells.
Nakamoto T; Okada H; Nakajima T; Ikuta A; Yasuda K; Kanzaki H
Hum Reprod; 2005 Jun; 20(6):1447-55. PubMed ID: 15774544
[TBL] [Abstract][Full Text] [Related]
17. Trimegestone differentially modulates the expression of matrix metalloproteinases in the endometrial stromal cell.
Wahab M; Taylor AH; Pringle JH; Thompson J; Al-Azzawi F
Mol Hum Reprod; 2006 Mar; 12(3):157-67. PubMed ID: 16556677
[TBL] [Abstract][Full Text] [Related]
18. Tibolone and its metabolites enhance tissue factor and PAI-1 expression in human endometrial stromal cells: Evidence of progestogenic effects.
Schatz F; Kuczynski E; Kloosterboer HJ; Buchwalder L; Tang C; Krikun G; Lockwood CJ
Steroids; 2005 Nov; 70(12):840-5. PubMed ID: 16011840
[TBL] [Abstract][Full Text] [Related]
19. Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
Slayden OD; Nayak NR; Burton KA; Chwalisz K; Cameron ST; Critchley HO; Baird DT; Brenner RM
J Clin Endocrinol Metab; 2001 Jun; 86(6):2668-79. PubMed ID: 11397870
[TBL] [Abstract][Full Text] [Related]
20. The possible use of antiprogestins for contraception.
Bygdeman M; Danielsson KG; Swahn ML
Acta Obstet Gynecol Scand Suppl; 1997; 164():75-7. PubMed ID: 9225644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
